SEC Filing Details
Document Details
Form
Filing Date
Feb 21, 2023
Document Date
Feb 21, 2023
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
Akari Therapeutics
Issuer
AKARI THERAPEUTICS PLC
